Advanced in Monoclonal Gammopathy of Undetermined Significance (MGUS)

Agathe Masseau

Nantes, FR 
Advanced in Monoclonal Gammopathy of Undetermined Significance (MGUS)
Nantes, FR 
OverviewLocationsClinical Research

Overview

Agathe Masseau practices in Nantes, France. Ms. Masseau is rated as an Advanced expert by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Gaucher Disease Type 1, Schnitzler Syndrome, Gaucher Disease, Splenectomy, and Kidney Transplant.

Her clinical research consists of co-authoring 79 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Monoclonal Gammopathy of Undetermined Significance (MGUS).

Gender
Female

Locations

Nantes, France
Other Locations
Rennes, France
Grenoble, France
Poitiers, France
Nantes, France
Strasbourg, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Multicentre Randomized Double-blind Placebo-controlled Study to Evaluate the Effect on Albuminuria of 6 Months Treatment With Hydroxycarbamide (Siklos®) or a Placebo in Adults With Sickle Cell Disease:
Multicentre Randomized Double-blind Placebo-controlled Study to Evaluate the Effect on Albuminuria of 6 Months Treatment With Hydroxycarbamide (Siklos®) or a Placebo in Adults With Sickle Cell Disease:
Enrollment Status: Completed
Publish Date: May 14, 2025
Intervention Type: Drug
Study Drug: Hydroxycarbamide
Study Phase: Phase 2
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2024
Intervention Type: Drug
Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and Preferences (SATIS-Fab)
Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and Preferences (SATIS-Fab)
Enrollment Status: Completed
Publish Date: May 23, 2024
Intervention Type: Behavioral
View 2 Less Clinical Trials

79 Total Publications

High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE).
High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE).
Journal: BMJ open
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Masseau's expertise for a condition
ConditionClose
    View All 38 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile